Morgan Cheatham Location
New York, United States
Morgan Cheatham Work
- 2020–nowLimited Partner @ First Close Partners
- Partner and Head of Healthcare and Life Sciences @ Breyer Capital
- Limited Partner @ Silver Beech Capital Management
- Co-Founder @ Decoding Bio
See more
- Chief Executive Officer (Interim) @ Folx Health
- Resident Physician @ Boston Children's Hospital
- Clinical and Research Student @ National Human Genome Research Institute (NHGRI)
- Board Member @ Coalition for Health AI (CHAI)
- NEJM AI Editorial Team @ NEJM Group
- 30U30 @ Forbes
- Vice President @ Bessemer Venture Partners
- Investment Banking Analyst @ Goldman Sachs
- Data Scientist @ Kyruus Health
- Data Scientist @ Kyruus
Morgan Cheatham Investing
Limited Partner at First Close Partners
- Stages
- Seed, Series A
- Sectors
- Health tech
- Cheque size
- €920k–€230M
- Freshness
- Verified 1mo ago
Morgan Cheatham Summary
Morgan Cheatham, based in New York, United States, is an Unknown at First Close Partners. Morgan Cheatham invests in Health tech at Seed and Series A, writing €920k–€230M cheques. Morgan Cheatham brings experience from Breyer Capital, Silver Beech Capital Management, Decoding Bio and Folx Health. Morgan Cheatham's verified email and contact details are available on Mintround.
How to cold email Morgan Cheatham
Morgan Cheatham, First Close Partners in New York, United States, backs Health tech companies at Seed and Series A, writing €920k–€230M cheques. Here's how to get a reply when you cold email Morgan:
- Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
- First line: your strongest traction, the real numbers, not adjectives.
- One ask: a 20-minute call with a date range. Keep it under 150 words.
- Send it to Morgan's verified address below. No warm intro required.
Every contact is a verified, deliverable email. How Mintround verifies contacts.
Are you Morgan Cheatham? Request removal of this listing.